Worth your time

Good news: the FDA keeps a database of potentially fatal surgical stapler failures. Bad news: the database was a secret until Christina Jewett of Kaiser Health News spotlighted it in an exposé last week. She got results: the FDA announced almost immediately it was reviewing the devices' safety and considering regulating them more closely. — Lev Facher

There are a whole host of companies working on microbiome-based drugs. STAT’s Kate Sheridan explores how the FDA is likely to regulate them. — Erin Mershon

The Wall Street Journal reports that Martin Shkreli is running his drug company from prison. Need I say more? — Nicholas Florko